Forte Biosciences

Forte Biosciences Acquired by Dutch Pharma Firm for $2.2B

by | Jul 28, 2026
The Dallas-based biopharma company focuses on treatment for autoimmune diseases.
MORE
Dallas’ Forte Biosciences Announces $53M Private Placement From Leading Healthcare Investors
by | Nov 21, 2024
Headquartered at Dallas' Pegasus Park, Forte Biosciences is developing a proprietary molecule with potentially broad autoimmune and autoimmune-related applications.
MORE